Pharma & Healthcare
Global Antimicrobial Peptides Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Aug 11, 25
- ID: 438712
- Pages: 98
- Figures: 93
- Views: 2
The global Antimicrobial Peptides market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
By Type: (Dominant Segment vs High-Margin Innovation)
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides
By Application: (Core Demand Driver vs Emerging Opportunity)
Pharmaceuticals
Feed Additives
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., AnaSpec in Europe)
- Emerging Product Trends: Plant Antimicrobial Peptides adoption vs. Microbial Antimicrobial Peptides premiumization
- Demand-Side Dynamics: Pharmaceuticals growth in China vs. Feed Additives potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Antimicrobial Peptides market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Microbial Antimicrobial Peptides in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Feed Additives in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Plant Antimicrobial Peptides dominance in Europe vs. Microbial Antimicrobial Peptides demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
Market Segmentation
By Company:
AnaSpec
AMP Biotech
Phoenix Biotech
Novabiotics
Chinese Peptide
Ontores
GenScript
Hycult Biotech
Sunsmile
Ruixing Biotechnology
Zhongnong Yingtai Biotechnology
Glam Technology
ProteLight Pharmaceutical & Biotechnology
By Type: (Dominant Segment vs High-Margin Innovation)
Plant Antimicrobial Peptides
Microbial Antimicrobial Peptides
Animal Antimicrobial Peptides
By Application: (Core Demand Driver vs Emerging Opportunity)
Pharmaceuticals
Feed Additives
Others
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., AnaSpec in Europe)
- Emerging Product Trends: Plant Antimicrobial Peptides adoption vs. Microbial Antimicrobial Peptides premiumization
- Demand-Side Dynamics: Pharmaceuticals growth in China vs. Feed Additives potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
(Additional regions can be customized based on client needs.)
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Antimicrobial Peptides market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Microbial Antimicrobial Peptides in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Feed Additives in India).
Chapter 6: Regional sales and revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
This is not just another market study. By fusing global trend analysis with hyper-local operational intelligence, we deliver:
- Risk-Controlled Market Entry: Navigate regulatory complexities in focus markets (e.g., China’s policies).
- Product Portfolio Optimization: Align offerings with regional preferences (e.g., Plant Antimicrobial Peptides dominance in Europe vs. Microbial Antimicrobial Peptides demand in MEA).
- Competitor Counterstrategies: Decode player tactics in fragmented vs. consolidated markets.
1 Market Overview
1.1 Antimicrobial Peptides Product Scope
1.2 Antimicrobial Peptides by Type
1.2.1 Global Antimicrobial Peptides Sales by Type (2020 & 2024 & 2031)
1.2.2 Plant Antimicrobial Peptides
1.2.3 Microbial Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.3 Antimicrobial Peptides by Application
1.3.1 Global Antimicrobial Peptides Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Pharmaceuticals
1.3.3 Feed Additives
1.3.4 Others
1.4 Global Antimicrobial Peptides Market Estimates and Forecasts (2020-2031)
1.4.1 Global Antimicrobial Peptides Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Antimicrobial Peptides Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Antimicrobial Peptides Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Antimicrobial Peptides Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Antimicrobial Peptides Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Antimicrobial Peptides Sales Market Share by Region (2020-2025)
2.2.2 Global Antimicrobial Peptides Revenue Market Share by Region (2020-2025)
2.3 Global Antimicrobial Peptides Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Antimicrobial Peptides Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Antimicrobial Peptides Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Antimicrobial Peptides Market Size and Prospective (2020-2031)
2.4.2 Europe Antimicrobial Peptides Market Size and Prospective (2020-2031)
2.4.3 China Antimicrobial Peptides Market Size and Prospective (2020-2031)
2.4.4 Japan Antimicrobial Peptides Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Antimicrobial Peptides Historic Market Review by Type (2020-2025)
3.1.1 Global Antimicrobial Peptides Sales by Type (2020-2025)
3.1.2 Global Antimicrobial Peptides Revenue by Type (2020-2025)
3.1.3 Global Antimicrobial Peptides Price by Type (2020-2025)
3.2 Global Antimicrobial Peptides Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Antimicrobial Peptides Sales Forecast by Type (2026-2031)
3.2.2 Global Antimicrobial Peptides Revenue Forecast by Type (2026-2031)
3.2.3 Global Antimicrobial Peptides Price Forecast by Type (2026-2031)
3.3 Different Types Antimicrobial Peptides Representative Players
4 Global Market Size by Application
4.1 Global Antimicrobial Peptides Historic Market Review by Application (2020-2025)
4.1.1 Global Antimicrobial Peptides Sales by Application (2020-2025)
4.1.2 Global Antimicrobial Peptides Revenue by Application (2020-2025)
4.1.3 Global Antimicrobial Peptides Price by Application (2020-2025)
4.2 Global Antimicrobial Peptides Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Antimicrobial Peptides Sales Forecast by Application (2026-2031)
4.2.2 Global Antimicrobial Peptides Revenue Forecast by Application (2026-2031)
4.2.3 Global Antimicrobial Peptides Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Antimicrobial Peptides Application
5 Competition Landscape by Players
5.1 Global Antimicrobial Peptides Sales by Players (2020-2025)
5.2 Global Top Antimicrobial Peptides Players by Revenue (2020-2025)
5.3 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2024)
5.4 Global Antimicrobial Peptides Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Antimicrobial Peptides, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Antimicrobial Peptides, Product Type & Application
5.7 Global Key Manufacturers of Antimicrobial Peptides, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Antimicrobial Peptides Sales by Company
6.1.1.1 North America Antimicrobial Peptides Sales by Company (2020-2025)
6.1.1.2 North America Antimicrobial Peptides Revenue by Company (2020-2025)
6.1.2 North America Antimicrobial Peptides Sales Breakdown by Type (2020-2025)
6.1.3 North America Antimicrobial Peptides Sales Breakdown by Application (2020-2025)
6.1.4 North America Antimicrobial Peptides Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Antimicrobial Peptides Sales by Company
6.2.1.1 Europe Antimicrobial Peptides Sales by Company (2020-2025)
6.2.1.2 Europe Antimicrobial Peptides Revenue by Company (2020-2025)
6.2.2 Europe Antimicrobial Peptides Sales Breakdown by Type (2020-2025)
6.2.3 Europe Antimicrobial Peptides Sales Breakdown by Application (2020-2025)
6.2.4 Europe Antimicrobial Peptides Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Antimicrobial Peptides Sales by Company
6.3.1.1 China Antimicrobial Peptides Sales by Company (2020-2025)
6.3.1.2 China Antimicrobial Peptides Revenue by Company (2020-2025)
6.3.2 China Antimicrobial Peptides Sales Breakdown by Type (2020-2025)
6.3.3 China Antimicrobial Peptides Sales Breakdown by Application (2020-2025)
6.3.4 China Antimicrobial Peptides Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Antimicrobial Peptides Sales by Company
6.4.1.1 Japan Antimicrobial Peptides Sales by Company (2020-2025)
6.4.1.2 Japan Antimicrobial Peptides Revenue by Company (2020-2025)
6.4.2 Japan Antimicrobial Peptides Sales Breakdown by Type (2020-2025)
6.4.3 Japan Antimicrobial Peptides Sales Breakdown by Application (2020-2025)
6.4.4 Japan Antimicrobial Peptides Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 AnaSpec
7.1.1 AnaSpec Company Information
7.1.2 AnaSpec Business Overview
7.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.1.4 AnaSpec Antimicrobial Peptides Products Offered
7.1.5 AnaSpec Recent Development
7.2 AMP Biotech
7.2.1 AMP Biotech Company Information
7.2.2 AMP Biotech Business Overview
7.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.2.4 AMP Biotech Antimicrobial Peptides Products Offered
7.2.5 AMP Biotech Recent Development
7.3 Phoenix Biotech
7.3.1 Phoenix Biotech Company Information
7.3.2 Phoenix Biotech Business Overview
7.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Phoenix Biotech Antimicrobial Peptides Products Offered
7.3.5 Phoenix Biotech Recent Development
7.4 Novabiotics
7.4.1 Novabiotics Company Information
7.4.2 Novabiotics Business Overview
7.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Novabiotics Antimicrobial Peptides Products Offered
7.4.5 Novabiotics Recent Development
7.5 Chinese Peptide
7.5.1 Chinese Peptide Company Information
7.5.2 Chinese Peptide Business Overview
7.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Chinese Peptide Antimicrobial Peptides Products Offered
7.5.5 Chinese Peptide Recent Development
7.6 Ontores
7.6.1 Ontores Company Information
7.6.2 Ontores Business Overview
7.6.3 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Ontores Antimicrobial Peptides Products Offered
7.6.5 Ontores Recent Development
7.7 GenScript
7.7.1 GenScript Company Information
7.7.2 GenScript Business Overview
7.7.3 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.7.4 GenScript Antimicrobial Peptides Products Offered
7.7.5 GenScript Recent Development
7.8 Hycult Biotech
7.8.1 Hycult Biotech Company Information
7.8.2 Hycult Biotech Business Overview
7.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Hycult Biotech Antimicrobial Peptides Products Offered
7.8.5 Hycult Biotech Recent Development
7.9 Sunsmile
7.9.1 Sunsmile Company Information
7.9.2 Sunsmile Business Overview
7.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Sunsmile Antimicrobial Peptides Products Offered
7.9.5 Sunsmile Recent Development
7.10 Ruixing Biotechnology
7.10.1 Ruixing Biotechnology Company Information
7.10.2 Ruixing Biotechnology Business Overview
7.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Ruixing Biotechnology Antimicrobial Peptides Products Offered
7.10.5 Ruixing Biotechnology Recent Development
7.11 Zhongnong Yingtai Biotechnology
7.11.1 Zhongnong Yingtai Biotechnology Company Information
7.11.2 Zhongnong Yingtai Biotechnology Business Overview
7.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Products Offered
7.11.5 Zhongnong Yingtai Biotechnology Recent Development
7.12 Glam Technology
7.12.1 Glam Technology Company Information
7.12.2 Glam Technology Business Overview
7.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Glam Technology Antimicrobial Peptides Products Offered
7.12.5 Glam Technology Recent Development
7.13 ProteLight Pharmaceutical & Biotechnology
7.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
7.13.2 ProteLight Pharmaceutical & Biotechnology Business Overview
7.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Products Offered
7.13.5 ProteLight Pharmaceutical & Biotechnology Recent Development
8 Antimicrobial Peptides Manufacturing Cost Analysis
8.1 Antimicrobial Peptides Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Antimicrobial Peptides
8.4 Antimicrobial Peptides Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Antimicrobial Peptides Distributors List
9.3 Antimicrobial Peptides Customers
10 Antimicrobial Peptides Market Dynamics
10.1 Antimicrobial Peptides Industry Trends
10.2 Antimicrobial Peptides Market Drivers
10.3 Antimicrobial Peptides Market Challenges
10.4 Antimicrobial Peptides Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
1.1 Antimicrobial Peptides Product Scope
1.2 Antimicrobial Peptides by Type
1.2.1 Global Antimicrobial Peptides Sales by Type (2020 & 2024 & 2031)
1.2.2 Plant Antimicrobial Peptides
1.2.3 Microbial Antimicrobial Peptides
1.2.4 Animal Antimicrobial Peptides
1.3 Antimicrobial Peptides by Application
1.3.1 Global Antimicrobial Peptides Sales Comparison by Application (2020 & 2024 & 2031)
1.3.2 Pharmaceuticals
1.3.3 Feed Additives
1.3.4 Others
1.4 Global Antimicrobial Peptides Market Estimates and Forecasts (2020-2031)
1.4.1 Global Antimicrobial Peptides Market Size in Value Growth Rate (2020-2031)
1.4.2 Global Antimicrobial Peptides Market Size in Volume Growth Rate (2020-2031)
1.4.3 Global Antimicrobial Peptides Price Trends (2020-2031)
1.5 Assumptions and Limitations
2 Market Size and Prospective by Region
2.1 Global Antimicrobial Peptides Market Size by Region: 2020 VS 2024 VS 2031
2.2 Global Antimicrobial Peptides Retrospective Market Scenario by Region (2020-2025)
2.2.1 Global Antimicrobial Peptides Sales Market Share by Region (2020-2025)
2.2.2 Global Antimicrobial Peptides Revenue Market Share by Region (2020-2025)
2.3 Global Antimicrobial Peptides Market Estimates and Forecasts by Region (2026-2031)
2.3.1 Global Antimicrobial Peptides Sales Estimates and Forecasts by Region (2026-2031)
2.3.2 Global Antimicrobial Peptides Revenue Forecast by Region (2026-2031)
2.4 Major Region and Emerging Market Analysis
2.4.1 North America Antimicrobial Peptides Market Size and Prospective (2020-2031)
2.4.2 Europe Antimicrobial Peptides Market Size and Prospective (2020-2031)
2.4.3 China Antimicrobial Peptides Market Size and Prospective (2020-2031)
2.4.4 Japan Antimicrobial Peptides Market Size and Prospective (2020-2031)
3 Global Market Size by Type
3.1 Global Antimicrobial Peptides Historic Market Review by Type (2020-2025)
3.1.1 Global Antimicrobial Peptides Sales by Type (2020-2025)
3.1.2 Global Antimicrobial Peptides Revenue by Type (2020-2025)
3.1.3 Global Antimicrobial Peptides Price by Type (2020-2025)
3.2 Global Antimicrobial Peptides Market Estimates and Forecasts by Type (2026-2031)
3.2.1 Global Antimicrobial Peptides Sales Forecast by Type (2026-2031)
3.2.2 Global Antimicrobial Peptides Revenue Forecast by Type (2026-2031)
3.2.3 Global Antimicrobial Peptides Price Forecast by Type (2026-2031)
3.3 Different Types Antimicrobial Peptides Representative Players
4 Global Market Size by Application
4.1 Global Antimicrobial Peptides Historic Market Review by Application (2020-2025)
4.1.1 Global Antimicrobial Peptides Sales by Application (2020-2025)
4.1.2 Global Antimicrobial Peptides Revenue by Application (2020-2025)
4.1.3 Global Antimicrobial Peptides Price by Application (2020-2025)
4.2 Global Antimicrobial Peptides Market Estimates and Forecasts by Application (2026-2031)
4.2.1 Global Antimicrobial Peptides Sales Forecast by Application (2026-2031)
4.2.2 Global Antimicrobial Peptides Revenue Forecast by Application (2026-2031)
4.2.3 Global Antimicrobial Peptides Price Forecast by Application (2026-2031)
4.3 New Sources of Growth in Antimicrobial Peptides Application
5 Competition Landscape by Players
5.1 Global Antimicrobial Peptides Sales by Players (2020-2025)
5.2 Global Top Antimicrobial Peptides Players by Revenue (2020-2025)
5.3 Global Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2024)
5.4 Global Antimicrobial Peptides Average Price by Company (2020-2025)
5.5 Global Key Manufacturers of Antimicrobial Peptides, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of Antimicrobial Peptides, Product Type & Application
5.7 Global Key Manufacturers of Antimicrobial Peptides, Date of Enter into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America Antimicrobial Peptides Sales by Company
6.1.1.1 North America Antimicrobial Peptides Sales by Company (2020-2025)
6.1.1.2 North America Antimicrobial Peptides Revenue by Company (2020-2025)
6.1.2 North America Antimicrobial Peptides Sales Breakdown by Type (2020-2025)
6.1.3 North America Antimicrobial Peptides Sales Breakdown by Application (2020-2025)
6.1.4 North America Antimicrobial Peptides Major Customer
6.1.5 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe Antimicrobial Peptides Sales by Company
6.2.1.1 Europe Antimicrobial Peptides Sales by Company (2020-2025)
6.2.1.2 Europe Antimicrobial Peptides Revenue by Company (2020-2025)
6.2.2 Europe Antimicrobial Peptides Sales Breakdown by Type (2020-2025)
6.2.3 Europe Antimicrobial Peptides Sales Breakdown by Application (2020-2025)
6.2.4 Europe Antimicrobial Peptides Major Customer
6.2.5 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China Antimicrobial Peptides Sales by Company
6.3.1.1 China Antimicrobial Peptides Sales by Company (2020-2025)
6.3.1.2 China Antimicrobial Peptides Revenue by Company (2020-2025)
6.3.2 China Antimicrobial Peptides Sales Breakdown by Type (2020-2025)
6.3.3 China Antimicrobial Peptides Sales Breakdown by Application (2020-2025)
6.3.4 China Antimicrobial Peptides Major Customer
6.3.5 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan Antimicrobial Peptides Sales by Company
6.4.1.1 Japan Antimicrobial Peptides Sales by Company (2020-2025)
6.4.1.2 Japan Antimicrobial Peptides Revenue by Company (2020-2025)
6.4.2 Japan Antimicrobial Peptides Sales Breakdown by Type (2020-2025)
6.4.3 Japan Antimicrobial Peptides Sales Breakdown by Application (2020-2025)
6.4.4 Japan Antimicrobial Peptides Major Customer
6.4.5 Japan Market Trend and Opportunities
7 Company Profiles and Key Figures
7.1 AnaSpec
7.1.1 AnaSpec Company Information
7.1.2 AnaSpec Business Overview
7.1.3 AnaSpec Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.1.4 AnaSpec Antimicrobial Peptides Products Offered
7.1.5 AnaSpec Recent Development
7.2 AMP Biotech
7.2.1 AMP Biotech Company Information
7.2.2 AMP Biotech Business Overview
7.2.3 AMP Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.2.4 AMP Biotech Antimicrobial Peptides Products Offered
7.2.5 AMP Biotech Recent Development
7.3 Phoenix Biotech
7.3.1 Phoenix Biotech Company Information
7.3.2 Phoenix Biotech Business Overview
7.3.3 Phoenix Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.3.4 Phoenix Biotech Antimicrobial Peptides Products Offered
7.3.5 Phoenix Biotech Recent Development
7.4 Novabiotics
7.4.1 Novabiotics Company Information
7.4.2 Novabiotics Business Overview
7.4.3 Novabiotics Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.4.4 Novabiotics Antimicrobial Peptides Products Offered
7.4.5 Novabiotics Recent Development
7.5 Chinese Peptide
7.5.1 Chinese Peptide Company Information
7.5.2 Chinese Peptide Business Overview
7.5.3 Chinese Peptide Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.5.4 Chinese Peptide Antimicrobial Peptides Products Offered
7.5.5 Chinese Peptide Recent Development
7.6 Ontores
7.6.1 Ontores Company Information
7.6.2 Ontores Business Overview
7.6.3 Ontores Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.6.4 Ontores Antimicrobial Peptides Products Offered
7.6.5 Ontores Recent Development
7.7 GenScript
7.7.1 GenScript Company Information
7.7.2 GenScript Business Overview
7.7.3 GenScript Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.7.4 GenScript Antimicrobial Peptides Products Offered
7.7.5 GenScript Recent Development
7.8 Hycult Biotech
7.8.1 Hycult Biotech Company Information
7.8.2 Hycult Biotech Business Overview
7.8.3 Hycult Biotech Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.8.4 Hycult Biotech Antimicrobial Peptides Products Offered
7.8.5 Hycult Biotech Recent Development
7.9 Sunsmile
7.9.1 Sunsmile Company Information
7.9.2 Sunsmile Business Overview
7.9.3 Sunsmile Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.9.4 Sunsmile Antimicrobial Peptides Products Offered
7.9.5 Sunsmile Recent Development
7.10 Ruixing Biotechnology
7.10.1 Ruixing Biotechnology Company Information
7.10.2 Ruixing Biotechnology Business Overview
7.10.3 Ruixing Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.10.4 Ruixing Biotechnology Antimicrobial Peptides Products Offered
7.10.5 Ruixing Biotechnology Recent Development
7.11 Zhongnong Yingtai Biotechnology
7.11.1 Zhongnong Yingtai Biotechnology Company Information
7.11.2 Zhongnong Yingtai Biotechnology Business Overview
7.11.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.11.4 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Products Offered
7.11.5 Zhongnong Yingtai Biotechnology Recent Development
7.12 Glam Technology
7.12.1 Glam Technology Company Information
7.12.2 Glam Technology Business Overview
7.12.3 Glam Technology Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.12.4 Glam Technology Antimicrobial Peptides Products Offered
7.12.5 Glam Technology Recent Development
7.13 ProteLight Pharmaceutical & Biotechnology
7.13.1 ProteLight Pharmaceutical & Biotechnology Company Information
7.13.2 ProteLight Pharmaceutical & Biotechnology Business Overview
7.13.3 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales, Revenue and Gross Margin (2020-2025)
7.13.4 ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Products Offered
7.13.5 ProteLight Pharmaceutical & Biotechnology Recent Development
8 Antimicrobial Peptides Manufacturing Cost Analysis
8.1 Antimicrobial Peptides Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of Antimicrobial Peptides
8.4 Antimicrobial Peptides Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
9.1 Marketing Channel
9.2 Antimicrobial Peptides Distributors List
9.3 Antimicrobial Peptides Customers
10 Antimicrobial Peptides Market Dynamics
10.1 Antimicrobial Peptides Industry Trends
10.2 Antimicrobial Peptides Market Drivers
10.3 Antimicrobial Peptides Market Challenges
10.4 Antimicrobial Peptides Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
List of Tables
Table 1. Global Antimicrobial Peptides Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Antimicrobial Peptides Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Antimicrobial Peptides Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Antimicrobial Peptides Sales (Mg) by Region (2020-2025)
Table 5. Global Antimicrobial Peptides Sales Market Share by Region (2020-2025)
Table 6. Global Antimicrobial Peptides Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Antimicrobial Peptides Revenue Share by Region (2020-2025)
Table 8. Global Antimicrobial Peptides Sales (Mg) Forecast by Region (2026-2031)
Table 9. Global Antimicrobial Peptides Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Antimicrobial Peptides Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Antimicrobial Peptides Revenue Share Forecast by Region (2026-2031)
Table 12. Global Antimicrobial Peptides Sales by Type (Mg) & (2020-2025)
Table 13. Global Antimicrobial Peptides Sales Share by Type (2020-2025)
Table 14. Global Antimicrobial Peptides Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Antimicrobial Peptides Price by Type (US$/Mg) & (2020-2025)
Table 16. Global Antimicrobial Peptides Sales by Type (Mg) & (2026-2031)
Table 17. Global Antimicrobial Peptides Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Antimicrobial Peptides Price by Type (US$/Mg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Antimicrobial Peptides Sales by Application (Mg) & (2020-2025)
Table 21. Global Antimicrobial Peptides Sales Share by Application (2020-2025)
Table 22. Global Antimicrobial Peptides Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Antimicrobial Peptides Price by Application (US$/Mg) & (2020-2025)
Table 24. Global Antimicrobial Peptides Sales by Application (Mg) & (2026-2031)
Table 25. Global Antimicrobial Peptides Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Antimicrobial Peptides Price by Application (US$/Mg) & (2026-2031)
Table 27. New Sources of Growth in Antimicrobial Peptides Application
Table 28. Global Antimicrobial Peptides Sales by Company (Mg) & (2020-2025)
Table 29. Global Antimicrobial Peptides Sales Share by Company (2020-2025)
Table 30. Global Antimicrobial Peptides Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Antimicrobial Peptides Revenue Share by Company (2020-2025)
Table 32. Global Antimicrobial Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2024)
Table 33. Global Market Antimicrobial Peptides Average Price by Company (US$/Mg) & (2020-2025)
Table 34. Global Key Manufacturers of Antimicrobial Peptides, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Antimicrobial Peptides, Product Type & Application
Table 36. Global Key Manufacturers of Antimicrobial Peptides, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Antimicrobial Peptides Sales by Company (2020-2025) & (Mg)
Table 39. North America Antimicrobial Peptides Sales Market Share by Company (2020-2025)
Table 40. North America Antimicrobial Peptides Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Antimicrobial Peptides Revenue Market Share by Company (2020-2025)
Table 42. North America Antimicrobial Peptides Sales by Type (2020-2025) & (Mg)
Table 43. North America Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Table 44. North America Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 45. North America Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Table 46. Europe Antimicrobial Peptides Sales by Company (2020-2025) & (Mg)
Table 47. Europe Antimicrobial Peptides Sales Market Share by Company (2020-2025)
Table 48. Europe Antimicrobial Peptides Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Antimicrobial Peptides Revenue Market Share by Company (2020-2025)
Table 50. Europe Antimicrobial Peptides Sales by Type (2020-2025) & (Mg)
Table 51. Europe Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Table 52. Europe Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 53. Europe Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Table 54. China Antimicrobial Peptides Sales by Company (2020-2025) & (Mg)
Table 55. China Antimicrobial Peptides Sales Market Share by Company (2020-2025)
Table 56. China Antimicrobial Peptides Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Antimicrobial Peptides Revenue Market Share by Company (2020-2025)
Table 58. China Antimicrobial Peptides Sales by Type (2020-2025) & (Mg)
Table 59. China Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Table 60. China Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 61. China Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Table 62. Japan Antimicrobial Peptides Sales by Company (2020-2025) & (Mg)
Table 63. Japan Antimicrobial Peptides Sales Market Share by Company (2020-2025)
Table 64. Japan Antimicrobial Peptides Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Antimicrobial Peptides Revenue Market Share by Company (2020-2025)
Table 66. Japan Antimicrobial Peptides Sales by Type (2020-2025) & (Mg)
Table 67. Japan Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Table 68. Japan Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 69. Japan Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Table 70. AnaSpec Company Information
Table 71. AnaSpec Description and Business Overview
Table 72. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 73. AnaSpec Antimicrobial Peptides Product
Table 74. AnaSpec Recent Development
Table 75. AMP Biotech Company Information
Table 76. AMP Biotech Description and Business Overview
Table 77. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 78. AMP Biotech Antimicrobial Peptides Product
Table 79. AMP Biotech Recent Development
Table 80. Phoenix Biotech Company Information
Table 81. Phoenix Biotech Description and Business Overview
Table 82. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 83. Phoenix Biotech Antimicrobial Peptides Product
Table 84. Phoenix Biotech Recent Development
Table 85. Novabiotics Company Information
Table 86. Novabiotics Description and Business Overview
Table 87. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 88. Novabiotics Antimicrobial Peptides Product
Table 89. Novabiotics Recent Development
Table 90. Chinese Peptide Company Information
Table 91. Chinese Peptide Description and Business Overview
Table 92. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 93. Chinese Peptide Antimicrobial Peptides Product
Table 94. Chinese Peptide Recent Development
Table 95. Ontores Company Information
Table 96. Ontores Description and Business Overview
Table 97. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 98. Ontores Antimicrobial Peptides Product
Table 99. Ontores Recent Development
Table 100. GenScript Company Information
Table 101. GenScript Description and Business Overview
Table 102. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 103. GenScript Antimicrobial Peptides Product
Table 104. GenScript Recent Development
Table 105. Hycult Biotech Company Information
Table 106. Hycult Biotech Description and Business Overview
Table 107. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 108. Hycult Biotech Antimicrobial Peptides Product
Table 109. Hycult Biotech Recent Development
Table 110. Sunsmile Company Information
Table 111. Sunsmile Description and Business Overview
Table 112. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 113. Sunsmile Antimicrobial Peptides Product
Table 114. Sunsmile Recent Development
Table 115. Ruixing Biotechnology Company Information
Table 116. Ruixing Biotechnology Description and Business Overview
Table 117. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 118. Ruixing Biotechnology Antimicrobial Peptides Product
Table 119. Ruixing Biotechnology Recent Development
Table 120. Zhongnong Yingtai Biotechnology Company Information
Table 121. Zhongnong Yingtai Biotechnology Description and Business Overview
Table 122. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 123. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
Table 124. Zhongnong Yingtai Biotechnology Recent Development
Table 125. Glam Technology Company Information
Table 126. Glam Technology Description and Business Overview
Table 127. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 128. Glam Technology Antimicrobial Peptides Product
Table 129. Glam Technology Recent Development
Table 130. ProteLight Pharmaceutical & Biotechnology Company Information
Table 131. ProteLight Pharmaceutical & Biotechnology Description and Business Overview
Table 132. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 133. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product
Table 134. ProteLight Pharmaceutical & Biotechnology Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Antimicrobial Peptides Distributors List
Table 138. Antimicrobial Peptides Customers List
Table 139. Antimicrobial Peptides Market Trends
Table 140. Antimicrobial Peptides Market Drivers
Table 141. Antimicrobial Peptides Market Challenges
Table 142. Antimicrobial Peptides Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Antimicrobial Peptides Product Picture
Figure 2. Global Antimicrobial Peptides Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Antimicrobial Peptides Sales Market Share by Type in 2024 & 2031
Figure 4. Plant Antimicrobial Peptides Product Picture
Figure 5. Microbial Antimicrobial Peptides Product Picture
Figure 6. Animal Antimicrobial Peptides Product Picture
Figure 7. Global Antimicrobial Peptides Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Antimicrobial Peptides Sales Market Share by Application in 2024 & 2031
Figure 9. Pharmaceuticals Examples
Figure 10. Feed Additives Examples
Figure 11. Others Examples
Figure 12. Global Antimicrobial Peptides Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Antimicrobial Peptides Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Antimicrobial Peptides Sales (Mg) Growth Rate (2020-2031)
Figure 15. Global Antimicrobial Peptides Price Trends Growth Rate (2020-2031) & (US$/Mg)
Figure 16. Antimicrobial Peptides Report Years Considered
Figure 17. Global Market Antimicrobial Peptides Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Antimicrobial Peptides Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Antimicrobial Peptides Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Antimicrobial Peptides Sales (Mg) Growth Rate (2020-2031)
Figure 21. Europe Antimicrobial Peptides Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Antimicrobial Peptides Sales (Mg) Growth Rate (2020-2031)
Figure 23. China Antimicrobial Peptides Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Antimicrobial Peptides Sales (Mg) Growth Rate (2020-2031)
Figure 25. Japan Antimicrobial Peptides Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Antimicrobial Peptides Sales (Mg) Growth Rate (2020-2031)
Figure 27. Global Antimicrobial Peptides Revenue Share by Type (2020-2025)
Figure 28. Global Antimicrobial Peptides Sales Share by Type (2026-2031)
Figure 29. Global Antimicrobial Peptides Revenue Share by Type (2026-2031)
Figure 30. Global Antimicrobial Peptides Revenue Share by Application (2020-2025)
Figure 31. Global Antimicrobial Peptides Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Antimicrobial Peptides Sales Share by Application (2026-2031)
Figure 33. Global Antimicrobial Peptides Revenue Share by Application (2026-2031)
Figure 34. Global Antimicrobial Peptides Sales Share by Company (2024)
Figure 35. Global Antimicrobial Peptides Revenue Share by Company (2024)
Figure 36. Global 5 Largest Antimicrobial Peptides Players Market Share by Revenue in Antimicrobial Peptides: 2020 & 2024
Figure 37. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Antimicrobial Peptides
Figure 39. Manufacturing Process Analysis of Antimicrobial Peptides
Figure 40. Antimicrobial Peptides Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Table 1. Global Antimicrobial Peptides Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)
Table 2. Global Antimicrobial Peptides Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)
Table 3. Global Market Antimicrobial Peptides Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Antimicrobial Peptides Sales (Mg) by Region (2020-2025)
Table 5. Global Antimicrobial Peptides Sales Market Share by Region (2020-2025)
Table 6. Global Antimicrobial Peptides Revenue (US$ Million) Market Share by Region (2020-2025)
Table 7. Global Antimicrobial Peptides Revenue Share by Region (2020-2025)
Table 8. Global Antimicrobial Peptides Sales (Mg) Forecast by Region (2026-2031)
Table 9. Global Antimicrobial Peptides Sales Market Share Forecast by Region (2026-2031)
Table 10. Global Antimicrobial Peptides Revenue (US$ Million) Forecast by Region (2026-2031)
Table 11. Global Antimicrobial Peptides Revenue Share Forecast by Region (2026-2031)
Table 12. Global Antimicrobial Peptides Sales by Type (Mg) & (2020-2025)
Table 13. Global Antimicrobial Peptides Sales Share by Type (2020-2025)
Table 14. Global Antimicrobial Peptides Revenue by Type (US$ Million) & (2020-2025)
Table 15. Global Antimicrobial Peptides Price by Type (US$/Mg) & (2020-2025)
Table 16. Global Antimicrobial Peptides Sales by Type (Mg) & (2026-2031)
Table 17. Global Antimicrobial Peptides Revenue by Type (US$ Million) & (2026-2031)
Table 18. Global Antimicrobial Peptides Price by Type (US$/Mg) & (2026-2031)
Table 19. Representative Players of Each Type
Table 20. Global Antimicrobial Peptides Sales by Application (Mg) & (2020-2025)
Table 21. Global Antimicrobial Peptides Sales Share by Application (2020-2025)
Table 22. Global Antimicrobial Peptides Revenue by Application (US$ Million) & (2020-2025)
Table 23. Global Antimicrobial Peptides Price by Application (US$/Mg) & (2020-2025)
Table 24. Global Antimicrobial Peptides Sales by Application (Mg) & (2026-2031)
Table 25. Global Antimicrobial Peptides Revenue Market Share by Application (US$ Million) & (2026-2031)
Table 26. Global Antimicrobial Peptides Price by Application (US$/Mg) & (2026-2031)
Table 27. New Sources of Growth in Antimicrobial Peptides Application
Table 28. Global Antimicrobial Peptides Sales by Company (Mg) & (2020-2025)
Table 29. Global Antimicrobial Peptides Sales Share by Company (2020-2025)
Table 30. Global Antimicrobial Peptides Revenue by Company (US$ Million) & (2020-2025)
Table 31. Global Antimicrobial Peptides Revenue Share by Company (2020-2025)
Table 32. Global Antimicrobial Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antimicrobial Peptides as of 2024)
Table 33. Global Market Antimicrobial Peptides Average Price by Company (US$/Mg) & (2020-2025)
Table 34. Global Key Manufacturers of Antimicrobial Peptides, Manufacturing Sites & Headquarters
Table 35. Global Key Manufacturers of Antimicrobial Peptides, Product Type & Application
Table 36. Global Key Manufacturers of Antimicrobial Peptides, Date of Enter into This Industry
Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 38. North America Antimicrobial Peptides Sales by Company (2020-2025) & (Mg)
Table 39. North America Antimicrobial Peptides Sales Market Share by Company (2020-2025)
Table 40. North America Antimicrobial Peptides Revenue by Company (2020-2025) & (US$ Million)
Table 41. North America Antimicrobial Peptides Revenue Market Share by Company (2020-2025)
Table 42. North America Antimicrobial Peptides Sales by Type (2020-2025) & (Mg)
Table 43. North America Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Table 44. North America Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 45. North America Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Table 46. Europe Antimicrobial Peptides Sales by Company (2020-2025) & (Mg)
Table 47. Europe Antimicrobial Peptides Sales Market Share by Company (2020-2025)
Table 48. Europe Antimicrobial Peptides Revenue by Company (2020-2025) & (US$ Million)
Table 49. Europe Antimicrobial Peptides Revenue Market Share by Company (2020-2025)
Table 50. Europe Antimicrobial Peptides Sales by Type (2020-2025) & (Mg)
Table 51. Europe Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Table 52. Europe Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 53. Europe Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Table 54. China Antimicrobial Peptides Sales by Company (2020-2025) & (Mg)
Table 55. China Antimicrobial Peptides Sales Market Share by Company (2020-2025)
Table 56. China Antimicrobial Peptides Revenue by Company (2020-2025) & (US$ Million)
Table 57. China Antimicrobial Peptides Revenue Market Share by Company (2020-2025)
Table 58. China Antimicrobial Peptides Sales by Type (2020-2025) & (Mg)
Table 59. China Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Table 60. China Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 61. China Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Table 62. Japan Antimicrobial Peptides Sales by Company (2020-2025) & (Mg)
Table 63. Japan Antimicrobial Peptides Sales Market Share by Company (2020-2025)
Table 64. Japan Antimicrobial Peptides Revenue by Company (2020-2025) & (US$ Million)
Table 65. Japan Antimicrobial Peptides Revenue Market Share by Company (2020-2025)
Table 66. Japan Antimicrobial Peptides Sales by Type (2020-2025) & (Mg)
Table 67. Japan Antimicrobial Peptides Sales Market Share by Type (2020-2025)
Table 68. Japan Antimicrobial Peptides Sales by Application (2020-2025) & (Mg)
Table 69. Japan Antimicrobial Peptides Sales Market Share by Application (2020-2025)
Table 70. AnaSpec Company Information
Table 71. AnaSpec Description and Business Overview
Table 72. AnaSpec Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 73. AnaSpec Antimicrobial Peptides Product
Table 74. AnaSpec Recent Development
Table 75. AMP Biotech Company Information
Table 76. AMP Biotech Description and Business Overview
Table 77. AMP Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 78. AMP Biotech Antimicrobial Peptides Product
Table 79. AMP Biotech Recent Development
Table 80. Phoenix Biotech Company Information
Table 81. Phoenix Biotech Description and Business Overview
Table 82. Phoenix Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 83. Phoenix Biotech Antimicrobial Peptides Product
Table 84. Phoenix Biotech Recent Development
Table 85. Novabiotics Company Information
Table 86. Novabiotics Description and Business Overview
Table 87. Novabiotics Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 88. Novabiotics Antimicrobial Peptides Product
Table 89. Novabiotics Recent Development
Table 90. Chinese Peptide Company Information
Table 91. Chinese Peptide Description and Business Overview
Table 92. Chinese Peptide Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 93. Chinese Peptide Antimicrobial Peptides Product
Table 94. Chinese Peptide Recent Development
Table 95. Ontores Company Information
Table 96. Ontores Description and Business Overview
Table 97. Ontores Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 98. Ontores Antimicrobial Peptides Product
Table 99. Ontores Recent Development
Table 100. GenScript Company Information
Table 101. GenScript Description and Business Overview
Table 102. GenScript Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 103. GenScript Antimicrobial Peptides Product
Table 104. GenScript Recent Development
Table 105. Hycult Biotech Company Information
Table 106. Hycult Biotech Description and Business Overview
Table 107. Hycult Biotech Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 108. Hycult Biotech Antimicrobial Peptides Product
Table 109. Hycult Biotech Recent Development
Table 110. Sunsmile Company Information
Table 111. Sunsmile Description and Business Overview
Table 112. Sunsmile Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 113. Sunsmile Antimicrobial Peptides Product
Table 114. Sunsmile Recent Development
Table 115. Ruixing Biotechnology Company Information
Table 116. Ruixing Biotechnology Description and Business Overview
Table 117. Ruixing Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 118. Ruixing Biotechnology Antimicrobial Peptides Product
Table 119. Ruixing Biotechnology Recent Development
Table 120. Zhongnong Yingtai Biotechnology Company Information
Table 121. Zhongnong Yingtai Biotechnology Description and Business Overview
Table 122. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 123. Zhongnong Yingtai Biotechnology Antimicrobial Peptides Product
Table 124. Zhongnong Yingtai Biotechnology Recent Development
Table 125. Glam Technology Company Information
Table 126. Glam Technology Description and Business Overview
Table 127. Glam Technology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 128. Glam Technology Antimicrobial Peptides Product
Table 129. Glam Technology Recent Development
Table 130. ProteLight Pharmaceutical & Biotechnology Company Information
Table 131. ProteLight Pharmaceutical & Biotechnology Description and Business Overview
Table 132. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Sales (Mg), Revenue (US$ Million), Price (US$/Mg) and Gross Margin (2020-2025)
Table 133. ProteLight Pharmaceutical & Biotechnology Antimicrobial Peptides Product
Table 134. ProteLight Pharmaceutical & Biotechnology Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Antimicrobial Peptides Distributors List
Table 138. Antimicrobial Peptides Customers List
Table 139. Antimicrobial Peptides Market Trends
Table 140. Antimicrobial Peptides Market Drivers
Table 141. Antimicrobial Peptides Market Challenges
Table 142. Antimicrobial Peptides Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Antimicrobial Peptides Product Picture
Figure 2. Global Antimicrobial Peptides Sales (US$ Million) by Type (2020 & 2024 & 2031)
Figure 3. Global Antimicrobial Peptides Sales Market Share by Type in 2024 & 2031
Figure 4. Plant Antimicrobial Peptides Product Picture
Figure 5. Microbial Antimicrobial Peptides Product Picture
Figure 6. Animal Antimicrobial Peptides Product Picture
Figure 7. Global Antimicrobial Peptides Sales (US$ Million) by Application (2020 & 2024 & 2031)
Figure 8. Global Antimicrobial Peptides Sales Market Share by Application in 2024 & 2031
Figure 9. Pharmaceuticals Examples
Figure 10. Feed Additives Examples
Figure 11. Others Examples
Figure 12. Global Antimicrobial Peptides Sales, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Antimicrobial Peptides Sales Growth Rate (2020-2031) & (US$ Million)
Figure 14. Global Antimicrobial Peptides Sales (Mg) Growth Rate (2020-2031)
Figure 15. Global Antimicrobial Peptides Price Trends Growth Rate (2020-2031) & (US$/Mg)
Figure 16. Antimicrobial Peptides Report Years Considered
Figure 17. Global Market Antimicrobial Peptides Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Figure 18. Global Antimicrobial Peptides Revenue Market Share by Region: 2020 VS 2024
Figure 19. North America Antimicrobial Peptides Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. North America Antimicrobial Peptides Sales (Mg) Growth Rate (2020-2031)
Figure 21. Europe Antimicrobial Peptides Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Europe Antimicrobial Peptides Sales (Mg) Growth Rate (2020-2031)
Figure 23. China Antimicrobial Peptides Revenue (US$ Million) Growth Rate (2020-2031)
Figure 24. China Antimicrobial Peptides Sales (Mg) Growth Rate (2020-2031)
Figure 25. Japan Antimicrobial Peptides Revenue (US$ Million) Growth Rate (2020-2031)
Figure 26. Japan Antimicrobial Peptides Sales (Mg) Growth Rate (2020-2031)
Figure 27. Global Antimicrobial Peptides Revenue Share by Type (2020-2025)
Figure 28. Global Antimicrobial Peptides Sales Share by Type (2026-2031)
Figure 29. Global Antimicrobial Peptides Revenue Share by Type (2026-2031)
Figure 30. Global Antimicrobial Peptides Revenue Share by Application (2020-2025)
Figure 31. Global Antimicrobial Peptides Revenue Growth Rate by Application in 2020 & 2024
Figure 32. Global Antimicrobial Peptides Sales Share by Application (2026-2031)
Figure 33. Global Antimicrobial Peptides Revenue Share by Application (2026-2031)
Figure 34. Global Antimicrobial Peptides Sales Share by Company (2024)
Figure 35. Global Antimicrobial Peptides Revenue Share by Company (2024)
Figure 36. Global 5 Largest Antimicrobial Peptides Players Market Share by Revenue in Antimicrobial Peptides: 2020 & 2024
Figure 37. Antimicrobial Peptides Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 38. Manufacturing Cost Structure of Antimicrobial Peptides
Figure 39. Manufacturing Process Analysis of Antimicrobial Peptides
Figure 40. Antimicrobial Peptides Industrial Chain
Figure 41. Channels of Distribution (Direct Vs Distribution)
Figure 42. Distributors Profiles
Figure 43. Bottom-up and Top-down Approaches for This Report
Figure 44. Data Triangulation
Figure 45. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232